Status report
Get it in writing
The official USPTO status record for XCELL AMNIO MATRIX, serial 88777128, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
XCELL AMNIO MATRIXSerial 88777128 · Principal Register
Live · Registered
Owner: Precise Bioscience Corporation
Class 005 - Pharmaceuticals
Filed Jan 29, 2020
Registered Mar 09, 2021
The record shows that “XCELL AMNIO MATRIX” is a live, registered mark on the Principal Register owned by Precise Bioscience Corporation. It protects the use of a biological amniotic membrane allograft for post‑surgery wound care, first used in commerce on December 1, 2019. A similar name would raise the closest concern in the same pharmaceutical field, especially for products or services involving amniotic membrane grafts. This registration does not give the owner control over every use of the words “XCELL,” “AMNIO,” or “MATRIX” in unrelated contexts. The prosecution history indicates a final refusal was issued on November 9, 2020, followed by a successful appeal and registration on March 9, 2021. The most recent event is the 2026 abandonment request under Section 7, which has not yet been acted upon. No oppositions or cancellations appear in the supplied history, so there is no visible enforcement activity. For someone considering a similar name, the record suggests a meaningful risk of conflict in the amniotic membrane wound‑care market.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.